Broyhill Cuts Avantor Position After Q2 Miss, Shares Down 16.2%
Broyhill Asset Management’s Q4 2025 letter cited Avantor as its largest detractor, with the position halved after management changes and Q2 results missed forecasts. Avantor shares fell 16.2% over one month, lost 45.1% over 52 weeks, trading at $9.06 as investors weigh its recovery levers.
1. Position Called Costly Mistake
Broyhill Asset Management’s fourth-quarter 2025 investor letter highlighted Avantor as its largest detractor, attributing losses to financial leverage and operational execution issues. The firm cut its Avantor stake by half following management changes and disappointing Q2 results that fell short of its recovery thesis.
2. Stock Performance Review
Avantor shares dropped 16.2% over the past month and plunged 45.1% over the last 52 weeks, closing at $9.06 on February 25, 2026. The company’s $6.18 billion market capitalization reflects investor skepticism amid prolonged cyclical downturn and heightened policy uncertainty.
3. Recovery Levers and Outlook
Broyhill maintained a reduced position, citing potential upside from revenue reacceleration, reshoring investments and recent pharmaceutical agreements that mitigate policy headwinds. The firm also highlighted the option of a strategic sale and noted that substantial sidelined capital could drive renewed interest if execution improves.